Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

AstraZeneca plc Company Profile (NYSE:AZN)

Consensus Ratings for AstraZeneca plc (NYSE:AZN) (?)
Ratings Breakdown: 4 Sell Rating(s), 6 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Hold (Score: 2.30)
Consensus Price Target: $74.00 (6.55% upside)

Current Analysts' Coverage Summary for AstraZeneca plc (NYSE:AZN)
Show:
DateFirmActionRatingPrice TargetActions
5/15/2015BNP ParibasReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Deutsche BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015BarclaysReiterated RatingUnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Credit SuisseReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015TheStreetUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015Berenberg BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Liberum CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Beaufort SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2015Kepler Capital MarketsReiterated RatingReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2015Societe GeneraleInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015ZacksReiterated RatingHold -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Panmure GordonReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015DanskeDowngradeSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015SEB Equity ResearchUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015Leerink SwannBoost Price Target$76.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014Morgan StanleyDowngradeEqual Weight -> UnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2014Bank of AmericaUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Prime WealthReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2014Galvan ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/20/2013Bryan Garnier & CieDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/20/2013NatixisBoost Price Target$53.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2013Nordea Equity ResearchUpgradeSell -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)